The support of continuing medical education by pharmaceutical companies

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Some drug companies have provided money for various CME programs with 'no strings attached'. Nevertheless, drug companies are no more altruistic than any other business, and they shouldn't be expected to be. They expect and deserve suitable recognition for their contributions. It is the author's impression that they recognize the value of CME both for the patients and for the physician and are involved for more than self-interest and commercial gain. Spending some of their advertising budget on CME is an accepted practice by most drug companies. These who produce and deliver CME programs should welcome their participation with suitable, mutually agreeable guidelines to ensure that the CME programs are conducted properly.

Original languageEnglish (US)
Pages (from-to)194-196
Number of pages3
JournalNew England Journal of Medicine
Volume300
Issue number4
StatePublished - 1979

Fingerprint

Continuing Medical Education
Pharmaceutical Preparations
Budgets
Guidelines
Physicians

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The support of continuing medical education by pharmaceutical companies. / Kaplan, Norman M.

In: New England Journal of Medicine, Vol. 300, No. 4, 1979, p. 194-196.

Research output: Contribution to journalArticle

@article{a640755bd56549c98c4fa7e7e822ab23,
title = "The support of continuing medical education by pharmaceutical companies",
abstract = "Some drug companies have provided money for various CME programs with 'no strings attached'. Nevertheless, drug companies are no more altruistic than any other business, and they shouldn't be expected to be. They expect and deserve suitable recognition for their contributions. It is the author's impression that they recognize the value of CME both for the patients and for the physician and are involved for more than self-interest and commercial gain. Spending some of their advertising budget on CME is an accepted practice by most drug companies. These who produce and deliver CME programs should welcome their participation with suitable, mutually agreeable guidelines to ensure that the CME programs are conducted properly.",
author = "Kaplan, {Norman M}",
year = "1979",
language = "English (US)",
volume = "300",
pages = "194--196",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "4",

}

TY - JOUR

T1 - The support of continuing medical education by pharmaceutical companies

AU - Kaplan, Norman M

PY - 1979

Y1 - 1979

N2 - Some drug companies have provided money for various CME programs with 'no strings attached'. Nevertheless, drug companies are no more altruistic than any other business, and they shouldn't be expected to be. They expect and deserve suitable recognition for their contributions. It is the author's impression that they recognize the value of CME both for the patients and for the physician and are involved for more than self-interest and commercial gain. Spending some of their advertising budget on CME is an accepted practice by most drug companies. These who produce and deliver CME programs should welcome their participation with suitable, mutually agreeable guidelines to ensure that the CME programs are conducted properly.

AB - Some drug companies have provided money for various CME programs with 'no strings attached'. Nevertheless, drug companies are no more altruistic than any other business, and they shouldn't be expected to be. They expect and deserve suitable recognition for their contributions. It is the author's impression that they recognize the value of CME both for the patients and for the physician and are involved for more than self-interest and commercial gain. Spending some of their advertising budget on CME is an accepted practice by most drug companies. These who produce and deliver CME programs should welcome their participation with suitable, mutually agreeable guidelines to ensure that the CME programs are conducted properly.

UR - http://www.scopus.com/inward/record.url?scp=0018347792&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018347792&partnerID=8YFLogxK

M3 - Article

VL - 300

SP - 194

EP - 196

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 4

ER -